Skip to main content

Articles

Page 5 of 150

  1. This study aimed to describe the clinical characteristics and analyze the poor prognostic factors in patients with anti-MDA5 dermatomyositis.

    Authors: Huyan Wang, Xin Chen, Yan Du, Lihua Wang, Qiyuan Wang, Huaxiang Wu, Lei Liu and Jing Xue
    Citation: Arthritis Research & Therapy 2023 25:127
  2. Anti-Jo-1 autoantibodies represent essential markers in the diagnosis of antisynthetase syndrome (ASS). In this retrospective study, we aimed to investigate whether their concentrations and fluctuations could ...

    Authors: Robin Arcani, Louise Rey, Alice Mazziotto, Daniel Bertin, Gilles Kaplanski, Pierre-André Jarrot, Pierre Lafforgue, Geoffroy Venton, Xavier Heim, Patrick Villani, Jean-Louis Mège, Alexandre Brodovitch and Nathalie Bardin
    Citation: Arthritis Research & Therapy 2023 25:125
  3. Rheumatoid arthritis (RA) patients have a 1.5- to twofold higher risk of developing heart failure (HF) and a twofold increased risk of HF-associated mortality compared to those without RA. HF is preceded subcl...

    Authors: Elizabeth Park, Kazato Ito, Christopher Depender, Jon T. Giles and Joan Bathon
    Citation: Arthritis Research & Therapy 2023 25:124
  4. To investigate the presence of different isotypes of anti-carbamylated protein (CarP) antibodies in systemic sclerosis (SSc) patients and its association with skin involvement.

    Authors: Sophie I. E. Liem, E. M. Hoekstra, E. W. Nivine Levarht, Annemarie L. Dorjee, Hans U. Scherer, René E. M. Toes, Tom W. J. Huizinga, Jeska K. de Vries-Bouwstra and Cynthia M. Fehres
    Citation: Arthritis Research & Therapy 2023 25:123
  5. Previous studies have revealed that Sirt3 deficiency is associated with several inflammatory responses. The purpose of this study is to investigate the role and potential molecular mechanisms of Sirt3 in the i...

    Authors: Linxi Lv, Hui Jiang, Dianze Song, Xiaoqin Zhou, Feng Chen, Long Ren, Yongen Xie and Mei Zeng
    Citation: Arthritis Research & Therapy 2023 25:121
  6. Neck pain (NP) is a common symptom reported in the elderly. However, no study has examined the relationship between NP and osteoarthritis (OA) so far, and this study aimed to investigate the association of nec...

    Authors: Xi Chen, Lihua Gong, Cheng Li, Siyuan Wang and Yixin Zhou
    Citation: Arthritis Research & Therapy 2023 25:120
  7. A proof-of-concept study to evaluate the feasibility and safety of minimally invasive ultrasound (US)-guided synovial biopsy of the radiocarpal (RC) joint using the anatomical snuffbox as an access route.

    Authors: Ludovico De Stefano, Serena Bugatti, Veronica Piccin, Gioacchino D’Ambrosio, Terenzj Luvaro, Blerina Xoxi, Carlomaurizio Montecucco and Antonio Manzo
    Citation: Arthritis Research & Therapy 2023 25:119
  8. Many clinical trial results are available to inform best practices in the treatment of patients with connective tissue disease-associated interstitial lung disease (CTD-ILD).

    Authors: Jean Paul Higuero Sevilla, Areeka Memon and Monique Hinchcliff
    Citation: Arthritis Research & Therapy 2023 25:118

    The Correction to this article has been published in Arthritis Research & Therapy 2023 25:132

  9. Intervertebral disc degeneration (IVDD) is closely associated with the structural damage in the annulus fibrosus (AF). Aberrant mechanical loading is an important inducement of annulus fibrosus cells (AFCs) ap...

    Authors: Chenhao Liu, Xiaoxin Gao, Jinhui Lou, Haiyin Li, Yuxuan Chen, Molong Chen, Yuyao Zhang, Zhilei Hu, Xian Chang, Menglin Luo, Yu Zhai and Changqing Li
    Citation: Arthritis Research & Therapy 2023 25:117
  10. Cerebrovascular ischemic events (CIE) are among the most severe complications of giant cell arteritis (GCA). Heterogeneity between different studies in the definition of GCA-related CIE leads to uncertainty re...

    Authors: Thomas Penet, Marc Lambert, Clio Baillet, Olivier Outteryck, Hilde Hénon, Sandrine Morell-Dubois, Eric Hachulla, David Launay and Mohammad Ryadh Pokeerbux
    Citation: Arthritis Research & Therapy 2023 25:116
  11. Comorbidities are common in patients with osteoarthritis (OA). This study aimed to determine the association of a wide range of previously diagnosed comorbidities in adults with newly diagnosed OA compared wit...

    Authors: Anne Kamps, Jos Runhaar, Maria A. J. de Ridder, Marcel de Wilde, Johan van der Lei, Weiya Zhang, Daniel Prieto-Alhambra, Martin Englund, Evelien I. T. de Schepper and Sita M. A. Bierma-Zeinstra
    Citation: Arthritis Research & Therapy 2023 25:114
  12. Osteoarthritis (OA) is a prevalent degenerative disease accompanied by the activation of innate and adaptive immune systems-associated inflammatory responses. Due to the local inflammation, the expression of v...

    Authors: Yuchen Zhang, Di Liu, Djandan Tadum Arthur Vithran, Bosomtwe Richmond Kwabena, Wenfeng Xiao and Yusheng Li
    Citation: Arthritis Research & Therapy 2023 25:113
  13. Lupus nephritis (LN) is one of the most severe complications of systemic lupus erythematosus (SLE). However, the current management of LN remains unsatisfactory due to sneaky symptoms during early stages and l...

    Authors: Xueyao Wang, Shaojie Fu, Jinyu Yu, Fuzhe Ma, Lihong Zhang, Jiahui Wang, Luyu Wang, Yue Tan, Huanfa Yi, Hao Wu and Zhonggao Xu
    Citation: Arthritis Research & Therapy 2023 25:112
  14. Systemic lupus erythematosus (SLE) is a clinically and biologically heterogeneous autoimmune disease. We explored whether the deconvolution of whole blood transcriptomic data could identify differences in pred...

    Authors: Mumina Akthar, Nisha Nair, Lucy M. Carter, Edward M. Vital, Emily Sutton, Neil McHugh, Ian N. Bruce and John A. Reynolds
    Citation: Arthritis Research & Therapy 2023 25:111

    The Correction to this article has been published in Arthritis Research & Therapy 2023 25:160

  15. To investigate the efficacy of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis (EGPA) and factors contributing to glucocorticoid (GC) discontinuation.

    Authors: Takashi Yamane and Akira Hashiramoto
    Citation: Arthritis Research & Therapy 2023 25:110
  16. To evaluate the real-world effect of the IL-12/23 inhibitor ustekinumab or of a tumour necrosis factor inhibitor (TNFi) on patient-reported outcomes (PRO) and their association with effectiveness endpoints in ...

    Authors: Laure Gossec, Stefan Siebert, Paul Bergmans, Kurt de Vlam, Elisa Gremese, Beatríz Joven-Ibáñez, Tatiana V. Korotaeva, Frederic Lavie, Wim Noël, Michael T. Nurmohamed, Petros P. Sfikakis, Mohamed Sharaf, Elke Theander and Josef S. Smolen
    Citation: Arthritis Research & Therapy 2023 25:109
  17. To compare body composition between patients with psoriatic disease (PsD), including cutaneous psoriasis (PsO) and psoriatic arthritis (PsA), and controls, and to explore associations between disease activity ...

    Authors: Tim Blake, Nicola J. Gullick, Charles E. Hutchinson, Abhir Bhalerao, Sarah Wayte, Andrew Weedall and Thomas M. Barber
    Citation: Arthritis Research & Therapy 2023 25:108

    The Correction to this article has been published in Arthritis Research & Therapy 2023 25:115

  18. An increased risk of pregnancy complications is seen in women with systemic lupus erythematosus (SLE), but the specific immunopathological drivers are still unclear. Hallmarks of SLE are granulocyte activation...

    Authors: Agnes Torell, Marit Stockfelt, Gunilla Larsson, Kaj Blennow, Henrik Zetterberg, Dag Leonard, Lars Rönnblom, Muna Saleh, Christopher Sjöwall, Helena Strevens, Andreas Jönsen, Anders A. Bengtsson, Estelle Trysberg, Maria Majcuk Sennström, Agneta Zickert, Elisabet Svenungsson…
    Citation: Arthritis Research & Therapy 2023 25:107
  19. Long-stranded non-coding RNA TUG1 is lowly expressed in osteoarthritic chondrocytes. This study aimed to elucidate the role of TUG1 in osteoarthritic cartilage damage and the underlying mechanisms.

    Authors: Nan-nan Liu, Yan-ping Huang, Yu-bao Shao, Xue-fei Fan, He-yan Sun, Tao-rong Wang, Tao Yao and Xiao-Yu Chen
    Citation: Arthritis Research & Therapy 2023 25:106
  20. Adult-onset Still’s disease (AOSD) is a systemic autoinflammatory disorder of unknown etiology. B cells are critical participants in different rheumatic diseases, and their roles in AOSD are rarely investigate...

    Authors: Xiangyu Fang, Hua Ye, Yang Xie, Chaonan Wei, Shuyan Liu, Haihong Yao, Zhanguo Li, Yuan Jia and Fanlei Hu
    Citation: Arthritis Research & Therapy 2023 25:104
  21. Polygenic risk score (PRS) analysis is used to predict disease risk. Although PRS has been shown to have great potential in improving clinical care, PRS accuracy assessment has been mainly focused on European ...

    Authors: Yugo Morita, Yoichiro Kamatani, Hiromu Ito, Shiro Ikegawa, Takahisa Kawaguchi, Shuji Kawaguchi, Meiko Takahashi, Chikashi Terao, Shuji Ito, Kohei Nishitani, Shinichiro Nakamura, Shinichi Kuriyama, Yasuharu Tabara, Fumihiko Matsuda and Shuichi Matsuda
    Citation: Arthritis Research & Therapy 2023 25:103
  22. Osteoarthritis (OA) is the most common form of arthritis, affecting millions of aging people. Investigation of abnormal glycosylation is essential for the understanding of pathological mechanisms of OA.

    Authors: Hanjie Yu, Mingxiu Li, Jian Shu, Liuyi Dang, Xin Wu, Yuzi Wang, Xuan Wang, Xin Chang, Xiaojuan Bao, Bojing Zhu, Xiameng Ren, Wentian Chen and Yi Li
    Citation: Arthritis Research & Therapy 2023 25:102
  23. Patients with rheumatoid arthritis (RA) have an increased risk of infection and malignancy compared with the general population. Infection risk is increased further with the use of disease-modifying antirheuma...

    Authors: Alyssa Dominique, Merete Lund Hetland, Axel Finckh, Jacques-Eric Gottenberg, Florenzo Iannone, Roberto Caporali, Tzuyung Douglas Kou, Dan Nordstrom, Maria Victoria Hernandez, Carlos Sánchez-Piedra, Fernando Sánchez-Alonso, Karel Pavelka, T. Christopher Bond and Teresa A. Simon
    Citation: Arthritis Research & Therapy 2023 25:101
  24. This post-hoc analysis of PsABio (NCT02627768) evaluated safety, effectiveness and treatment persistence in patients < 60 and ≥ 60 years of age receiving ustekinumab over 3 years.

    Authors: Laure Gossec, Elke Theander, Soumya D. Chakravarty, Paul Bergmans, Frederic Lavie, Wim Noël, Mohamed Sharaf, Stefan Siebert and Josef S. Smolen
    Citation: Arthritis Research & Therapy 2023 25:100
  25. In axial spondyloarthritis (axSpA), peripheral SpA (pSpA) and psoriatic arthritis (PsA), enthesitis is a hallmark clinical feature that can be assessed by the SPARCC index, LEI, MASES and MEI. These indices ev...

    Authors: Raquel Ena María Granados, M. Lourdes Ladehesa-Pineda, M. Ángeles Puche-Larrubia, Alejandro Escudero-Contreras, Maxime Dougados, Eduardo Collantes-Estevez and Clementina López-Medina
    Citation: Arthritis Research & Therapy 2023 25:99
  26. It is unclear whether sex or age modify the association of glucocorticoid (GC) use with reduced bone mineral density (BMD) in patients with rheumatoid arthritis (RA).

    Authors: Andriko Palmowski, Zhivana Boyadzhieva, Sabrina M. Nielsen, Burkhard Muche, Sandra Hermann, Maarten Boers, Henning Bliddal, Robin Christensen, Edgar Wiebe and Frank Buttgereit
    Citation: Arthritis Research & Therapy 2023 25:98
  27. Lymphocyte activation gene-3 (LAG-3) inhibits T cell activation and interferes with the immune response by binding to MHC-II. As antigen presentation is central in rheumatoid arthritis (RA) pathogenesis, we st...

    Authors: Janni Maria Pedersen, Aida Solhøj Hansen, Cæcilie Skejø, Kristian Juul-Madsen, Peter Junker, Kim Hørslev-Petersen, Merete Lund Hetland, Kristian Stengaard-Pedersen, Mikkel Østergaard, Bjarne Kuno Møller, Lene Dreyer, Ellen-Margrethe Hauge, Malene Hvid, Stinne Greisen and Bent Deleuran
    Citation: Arthritis Research & Therapy 2023 25:97
  28. High-temperature requirement serine protease A 2 (HtrA2) is known to be involved in growth, unfolded protein response to stress, apoptosis, and autophagy. However, whether HtrA2 controls inflammation and immun...

    Authors: Gi Heon Jeong, Min-Kyung Nam, Wonhee Hur, Seolhee Heo, Saseong Lee, Eunbyeol Choi, Jae Hyung Park, Youngjae Park, Wan-Uk Kim, Hyangshuk Rhim and Seung-Ah Yoo
    Citation: Arthritis Research & Therapy 2023 25:96
  29. Intestinal inflammation, dysbiosis, intestinal permeability (IP), and bacterial translocation (BT) have been identified in patients with spondyloarthritis but the time at which they appear and their contributi...

    Authors: Sophie Hecquet, Perle Totoson, Hélène Martin, Marie-Paule Algros, Philippe Saas, Jean-Paul Pais-de-Barros, Alban Atchon, Benoît Valot, Didier Hocquet, Maude Tournier, Clément Prati, Daniel Wendling, Céline Demougeot and Frank Verhoeven
    Citation: Arthritis Research & Therapy 2023 25:95
  30. Knee osteoarthritis (OA) is a multifactorial form of rheumatic condition contributing to physical and psychological factors. Treatments have been provided solely and often compared with each other. An alternat...

    Authors: Pouya Rabiei, Bahram Sheikhi and Amir Letafatkar
    Citation: Arthritis Research & Therapy 2023 25:94
  31. Many patients with rheumatoid arthritis (RA) require a trial of multiple biologic disease-modifying anti-rheumatic drugs (bDMARDs) to control their disease. With the availability of several bDMARD options, the...

    Authors: Priyam Das, Dana Weisenfeld, Kumar Dahal, Debsurya De, Vivi Feathers, Jonathan S. Coblyn, Michael E. Weinblatt, Nancy A. Shadick, Tianxi Cai and Katherine P. Liao
    Citation: Arthritis Research & Therapy 2023 25:93
  32. This study aimed to investigate the expression profile of immune response-related proteins of Behcet’s disease (BD) patients and identify potential biomarkers for this disease.

    Authors: Huan Liu, Panpan Zhang, Fuzhen Li, Xiao Xiao, Yinan Zhang, Na Li, Liping Du and Peizeng Yang
    Citation: Arthritis Research & Therapy 2023 25:92
  33. In Switzerland, rituximab (RTX) is licenced for the treatment of rheumatoid arthritis (RA) and ANCA-associated vasculitis (AAV) but is frequently used off-label to treat other auto-immune diseases (AID), espec...

    Authors: Alexandre Dumusc, Fahad Alromaih, Matthieu Perreau, Thomas Hügle, Pascal Zufferey and Diana Dan
    Citation: Arthritis Research & Therapy 2023 25:91
  34. To evaluate baseline hemoglobin (Hb) and radiographic progression over time in patients enrolled in the Brigham and Women’s Rheumatoid Arthritis Sequential Study (BRASS) registry.

    Authors: Nancy Shadick, Owen Hagino, Amy Praestgaard, Stefano Fiore, Michael Weinblatt and Gerd Burmester
    Citation: Arthritis Research & Therapy 2023 25:88
  35. Dopamine is a neurotransmitter and has been found to regulate lymphocytes by acting on dopamine receptors (DRs). CD4+ T cells express all the five subtypes of DRs, D1R to D5R. Although CD4+ T cells have been invo...

    Authors: Xiao-Qin Wang, Huan-Huan Cai, Qiao-Wen Deng, Ya-Zhou Chang, Yu-Ping Peng and Yi-Hua Qiu
    Citation: Arthritis Research & Therapy 2023 25:87
  36. The objectives of this study were to assess the discontinuation of biologic therapy in patients who achieve remission and identify predictors of discontinuation of biologics in patients with inflammatory arthr...

    Authors: Marta Valero, Carlos Sánchez-Piedra, Mercedes Freire, María Colazo, Noemí Busquets, Erardo Meriño-Ibarra, Carlos Rodríguez-Lozano, Sara Manrique, Cristina Campos, Fernando Sánchez-Alonso and Isabel Castrejón
    Citation: Arthritis Research & Therapy 2023 25:86

    The Correction to this article has been published in Arthritis Research & Therapy 2023 25:210

  37. Insulin resistance affects a substantial proportion of patients with rheumatoid arthritis (RA). Skeletal muscle mitochondrial dysfunction results in the accumulation of lipid intermediates that interfere with ...

    Authors: Douglas R. Moellering, Kelley Smith-Johnston, Christian Kelley, Melissa J. Sammy, Jason Benedict, Guy Brock, Jillian Johnson, Kedryn K. Baskin, Wael N. Jarjour, Martha A. Belury, Peter J. Reiser, Prabhakara R. Nagareddy and Beatriz Y. Hanaoka
    Citation: Arthritis Research & Therapy 2023 25:85
  38. Systemic sclerosis (SSc) is a multi-organ disease with impaired health-related quality of life (HRQoL). The EULAR SSc Impact of Disease (ScleroID) is a newly introduced SSc-specific patient-reported outcome to...

    Authors: Gabriella Nagy, Rucsandra Dobrota, Mike Oliver Becker, Tünde Minier, Cecília Varjú, Gábor Kumánovics, Oliver Distler and László Czirják
    Citation: Arthritis Research & Therapy 2023 25:84
  39. Investigation of cartilage and chondrocytes has revealed that the osteoarthritis risk marked by the independent DNA variants rs11583641 and rs1046934 mediate  their effects by decreasing the methylation status...

    Authors: Yulia S. Kehayova, J. Mark Wilkinson, Sarah J. Rice and John Loughlin
    Citation: Arthritis Research & Therapy 2023 25:83
  40. Leucovorin (folinic acid) is a commonly used antidote for severe toxicity with low-dose methotrexate, but its optimum dose is unclear, varying from 15 to 25 mg every 6-h.

    Authors: Mudit Bhargava, Chirag Rajkumar Kopp, Shankar Naidu, Deba Prasad Dhibar, Atul Saroch, Alka Khadwal, Tarun Narang, Siddharth Jain, Aastha Khullar, Bidya Leishangthem, Aman Sharma, Susheel Kumar, Shefali Sharma, Sanjay Jain and Varun Dhir
    Citation: Arthritis Research & Therapy 2023 25:82
  41. Previous studies have repeatedly found distinct brain morphometric changes in patients with fibromyalgia (FM), mainly affecting gray and white matter abnormalities in areas related to sensory and affective pai...

    Authors: Benjamin Mosch, Verena Hagena, Stephan Herpertz and Martin Diers
    Citation: Arthritis Research & Therapy 2023 25:81

    The Correction to this article has been published in Arthritis Research & Therapy 2023 25:89

  42. Radiographic progression and course of inflammation over 2 years in patients with non-radiographic axial spondyloarthritis (nr-axSpA) from the phase 3, randomized, PREVENT study are reported here.

    Authors: Juergen Braun, Ricardo Blanco, Helena Marzo-Ortega, Lianne S. Gensler, Filip Van den Bosch, Stephen Hall, Hideto Kameda, Denis Poddubnyy, Marleen van de Sande, Désirée van der Heijde, Tingting Zhuang, Anna Stefanska, Aimee Readie, Hanno B. Richards and Atul Deodhar
    Citation: Arthritis Research & Therapy 2023 25:80
  43. Based on the results of existing observational studies, it can be found that the association between serum vitamin D levels and the risk of Sjogren’s syndrome (SS) in humans is still controversial. Based on th...

    Authors: Meng Zhao, Feiran Wei, Han Li, Zemin Wang, Shuai Wang, Yangyang Liu, Gaoqiang Fei, You Ge and Pingmin Wei
    Citation: Arthritis Research & Therapy 2023 25:79
  44. To describe the clinical phenotype and prognosis of people in the Australian Scleroderma (SSc) Cohort Study with pulmonary arterial hypertension (PAH) with or without interstitial lung disease (ILD).

    Authors: Jessica L. Fairley, Dylan Hansen, Laura Ross, Susanna Proudman, Joanne Sahhar, Gene-Siew Ngian, Jennifer Walker, Lauren V. Host, Kathleen Morrisroe, Diane Apostolopoulous, Nava Ferdowsi, Michelle Wilson, Maryam Tabesh, Wendy Stevens and Mandana Nikpour
    Citation: Arthritis Research & Therapy 2023 25:77

Annual Journal Metrics

  • 2022 Citation Impact
    4.9 - 2-year Impact Factor
    5.7 - 5-year Impact Factor
    1.501 - SNIP (Source Normalized Impact per Paper)
    1.592 - SJR (SCImago Journal Rank)

    2023 Speed
    11 days submission to first editorial decision for all manuscripts (Median)
    111 days submission to accept (Median)

    2023 Usage 
    3,331,819 downloads
    1,885 Altmetric mentions